Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/15/2010CN101215325B Antibiotic peptides, preparation method and application thereof
12/15/2010CN101204489B Hydropathic compress medicine for verruca plana
12/15/2010CN101204475B Marinating medicine for hands and feet cutaneous pruritus
12/15/2010CN101199597B Traditional Chinese medicament for treating acute appendicitis
12/15/2010CN101186633B Saponin antimycotic compounds in holothuria scabra jaeger and preparation method thereof
12/15/2010CN101176722B Scutellaria glycosides freeze dried injection solution and preparation method thereof
12/15/2010CN101163703B Imidazo [1, 2-a]pyridine derivatives useful as peptide deformylase (pdf) inhibitors
12/15/2010CN101153028B Compounds with antimicrobial antiviral activity
12/15/2010CN101148460B Azithromycin derivative and application thereof
12/15/2010CN101077174B Tea soup with indigestion and stomach nourishing health function
12/15/2010CN101041011B Chinese traditional medicine for preventing and curing AIDS
12/15/2010CN101031321B Perorally administrable antimicrobial composition
12/15/2010CN101022797B Novel use of alpha-sympathomimetics having a 2-imidazoline structure
12/14/2010US7851607 Expression vector comprising nucleotide sequences coding porcine reproductive and respiratory syndrome polypeptide for use in generating vaccine to prevent viral infection; immunotherapy
12/14/2010US7851594 Human cytokine receptor
12/14/2010US7851439 useful in interfering with the life cycle of bacteria and in treating or preventing a bacterial infection
12/14/2010US7851183 Nucleotide sequences coding modified polyketide synthase for use in development of pharmaceutical, agricultural and/or veterinary products
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7850996 Therapy, prevention of papillomavirus infections; antiinflammatory agents; wound healing agents
12/14/2010US7850993 Drug-releasing system of biodegradable polymer type
12/14/2010US7850980 Chlamydia OMP antigen
12/14/2010US7850974 Using sequences infomation to identify microbial surface components recognizing adhesive matrix molecules (MSCRAMM proteins) in order to diagnose, treat and prevent bacterial infection
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010US7850956 Immunization by inoculation of DNA transcription unit
12/14/2010CA2558026C Hiv integrase inhibitors
12/14/2010CA2535199C Amide derivative
12/14/2010CA2504755C Carbohydrate-based synthetic vaccines for hiv
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2478811C Tasted masked veterinary solid compositions
12/14/2010CA2461890C Water soluble nanoparticles of hydrophilic and hydrophobic active materials
12/14/2010CA2430909C Inhibitors of papilloma virus
12/14/2010CA2400737C Nutritional formulation containing prebiotic substances
12/14/2010CA2394946C Method of inactivating microorganisms
12/14/2010CA2391274C Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
12/14/2010CA2365392C Vaccine preparation containing fatty acid as a constituent
12/14/2010CA2351010C A broad spectrum infectious bursal disease virus vaccine
12/14/2010CA2308116C Low-toxicity human interferon-alpha analog
12/14/2010CA2287520C Enzymatic dna molecules
12/09/2010WO2010141511A2 Polynucleotides for multivalent rna interference, compositions and methods of use thereof
12/09/2010WO2010141133A2 Silk fibroin systems for antibiotic delivery
12/09/2010WO2010140377A1 Vaccine for mycoplasma infection
12/09/2010WO2010140114A1 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine -origin influenza a (h1n1) virus (s-oiv) infections
12/09/2010WO2010139805A1 Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections
12/09/2010WO2010139539A1 Pharmaceutical compositions containing antifungal peptides
12/09/2010WO2010139193A1 Hand-foot-mouth disease vaccine, preparation method and uses thereof
12/09/2010WO2010139064A1 Method of treating staphylococcal infection
12/09/2010WO2010139048A1 Human milk peptides
12/09/2010WO2010139047A1 Reagents and methods for detecting influenza virus proteins
12/09/2010WO2010115836A4 Substituted piperidines as ccr3 antagonists
12/09/2010WO2010095858A3 Pharmaceutical composition containing rhei rhizoma extract, fractions thereof, or stilbene-based compounds for preventing or treating diseases mediated by intercellular adhesion molecule-1
12/09/2010WO2010091386A3 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
12/09/2010WO2010062396A3 Virus like particle compositions and methods of use
12/09/2010WO2010020789A3 Medicament combination comprising alkaloids and a purine analog antiviral agent
12/09/2010US20100313298 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine
12/09/2010US20100312312 Method for selective photodynamic therapy and light source for implementation thereof
12/09/2010US20100311840 Oral formulations of bis(thiohydrazide amides)
12/09/2010US20100311832 Lactylates for the prevention and treatment of infections caused by gram positive bacteria in animals
12/09/2010US20100311827 Chlorogenic acid derivatives and their use as anti-fungal agents
12/09/2010US20100311817 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311809 Viral vector system, a composition comprising the viral vector system and its use
12/09/2010US20100311808 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES
12/09/2010US20100311791 N-halogenated amino compounds and derivatives
12/09/2010US20100311779 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
12/09/2010US20100311766 Antibacterial compositions
12/09/2010US20100311760 Heterocyclic antiviral compounds
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311735 Inhibitors of human immunodeficiency virus replication
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311731 Fluoroquinolone Carboxylic Acid Molecular Crystals
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311684 Novel tricyclic nucleosides or nucleotides as therapeutic agents
12/09/2010US20100311681 Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same
12/09/2010US20100311680 Synthesis of novel neamine derivatives and use thereof as antibacterial agents
12/09/2010US20100311656 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
12/09/2010US20100311646 Method of inhibiting clostridium difficile by administration of oritavancin
12/09/2010US20100311643 Use of glp-1 as a therapeutic agent
12/09/2010US20100311641 Peptide-based body surface coloring reagents
12/09/2010US20100311595 Lipophilic drug delivery vehicle and methods of use thereof
12/09/2010US20100311120 Human cytokine receptor
12/09/2010US20100311105 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/09/2010US20100311088 Recombinant antigens for diagnosis and prevention of murine typhus
12/09/2010US20100310684 Methods for treating and preventing mucositis
12/09/2010US20100310673 Substance and composition both capable of imparting heat resistance
12/09/2010US20100310670 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
12/09/2010US20100310669 Dispersion of Poloxamer- Protein Particles, Methods of Manufacturing and Uses Thereof
12/09/2010US20100310665 Bacteriostatic or bacteriocidal compositions and methods
12/09/2010US20100310662 Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin
12/09/2010US20100310656 Immunotherapy and prevention of autoimmune hepatitis
12/09/2010US20100310638 Liposomes comprising duramycin and anti-viral agents
12/09/2010US20100310631 Filament based on hyaluronic acid in the form of free acid and method for obtaining it
12/09/2010US20100310621 Controlled Iodine Release Particle Micro-Biocide
12/09/2010US20100310605 anti-hcv vaccine and preparation methods and uses thereof
12/09/2010US20100310604 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
12/09/2010US20100310603 TEM8 as an Adjuvant and Uses Thereof
12/09/2010US20100310602 Synthetic glucopyranosyl lipid adjuvants
12/09/2010US20100310600 Selective agonist of toll-like receptor 3
1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 1798